Cargando…
Breast cancer risk for women with diabetes and the impact of metformin: A meta‐analysis
BACKGROUND: Diabetes mellitus has been associated with increased breast cancer (BC) risk; however, the magnitude of this effect is uncertain. This study focused on BC risk for women with type 2 diabetes mellitus (T2DM). METHODS: Two separate meta‐analyses were conducted (1) to estimate the relative...
Autores principales: | Lu, Yifan, Hajjar, Ali, Cryns, Vincent L., Trentham‐Dietz, Amy, Gangnon, Ronald E., Heckman‐Stoddard, Brandy M., Alagoz, Oguzhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242307/ https://www.ncbi.nlm.nih.gov/pubmed/36533539 http://dx.doi.org/10.1002/cam4.5545 |
Ejemplares similares
-
Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer
por: Hajjar, Ali, et al.
Publicado: (2019) -
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
por: Lee, Christine G., et al.
Publicado: (2021) -
Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts
por: Trentham-Dietz, Amy, et al.
Publicado: (2021) -
Metabolic Surgery and Cancer Risk: An Opportunity for Mechanistic Research
por: Sauter, Edward R., et al.
Publicado: (2021) -
Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women
por: van Ravesteyn, Nicolien T, et al.
Publicado: (2021)